Drug intelligence / Profile preview

baoxianzi

Development stage
Unknown
Lead developer
Yunnan Baiyao
Administration
Oral
01

Overview

Baoxianzi (also known as the Insurance Pill or Safety Pill) is a small, concentrated red pill traditionally included in the packaging of Yunnan Baiyao, a proprietary Traditional Chinese Medicine (TCM). While the full formula of Yunnan Baiyao is a protected state secret in China, it is primarily composed of *Panax notoginseng* and other herbal extracts. Baoxianzi is traditionally reserved for emergency situations involving severe trauma, hemorrhage, or shock to prevent collapse. Recent clinical investigations, such as those conducted by Henan Cancer Hospital, are evaluating the efficacy of Baoxianzi when used in combination with standard Yunnan Baiyao capsules for the relief of mild to moderate cancer-related pain, potentially leveraging its anti-inflammatory and analgesic properties.

Brand names
Yunnan Baiyao
Other names
Insurance PillSafety PillRed PillBaoxian Zi
02

Targets

GPIIb/IIIa (Integrin alpha-IIb/beta-3)

Beyond the preview

Go deeper on baoxianzi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on baoxianzi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call